CME (CME Group) GF Value : $239.90 (As of Apr. 27, 2025)

View and export this data going back to 2002. Start your Free Trial

What is CME Group GF Value?

As of today (2025-04-27), CME Group's share price is $266.30. CME Group's GF Value is $239.90. Therefore, CME Group's Price-to-GF-Value for today is 1.11. Based on the relationship between the current stock price and the GF Value, GuruFocus believes CME Group is Modestly Overvalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

CME Group (NAS:CME) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (1)
Possible Value Trap, Think Twice	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)	Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.

Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.

CME Group's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	266.30	/	239.90
	=	1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group GF Value Related Terms

Thank you for viewing the detailed overview of CME Group's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CME Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

CME:Mexico 0HR2:UK MX4A:Germany MX4A:Germany CHME34:Brazil CMEG:Austria

Address

20 South Wacker Drive, Chicago, IL, USA, 60606

Website

https://www.cmegroup.com

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Executives

William R Shepard	director	20 S. WACKER DR, CHICAGO IL 60606
Howard J Siegel	director	20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy	director	20 S. WACKER DR, CHICAGO IL 60606
Suzanne Sprague	officer: Sr MD Global Head of Clearing	20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Hilda Harris Piell	officer: MD, Organizational Development	20 S. WACKER DRIVE, CHICAGO IL 60606
Ken Vroman	officer: MD & Chief Corp Dev Officer	20 S. WACKER DR., CHICAGO IL 60606
Julie Winkler	officer: Chief Commercial Officer	20 S. WACKER DR., CHICAGO IL 60606
Elizabeth A Cook	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman	director	20 S. WACKER DR, CHICAGO IL 60606
Timothy S. Bitsberger	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho	officer: President, CME Clearing	20 S. WACKER DR., CHICAGO IL 60606
Timothy Francis Mccourt	officer: Sr MD Global Head Equity & FX	20 S WACKER DRIVE, CHICAGO IL 60606
Lynne Fitzpatrick	officer: Sr MD Deputy CFO	20 S WACKER DRIVE, CHICAGO IL 60606
Bryan T Durkin	officer: MD & COO	20 S. WACKER DRIVE, CHICAGO IL 60606
Charles P Carey	director	20 S. WACKER DRIVE, CHICAGO IL 60606